Wednesday, June 27, 2018

Evolution in Biodegradable Bubble Wrap Packaging to Boost Asia’s Bubble Wrap Packaging Industry-Ken Research


According to the study “Asia Bubble Wrap Packaging Industry Situation and Prospects Research report”, Asian bubble wrap packaging market offers innovative packaging products at reduced costs which is posing a stiff competition among the leading players. The leading vendors in Asia bubble wrap packaging industry are Automated Packaging Systems, Pregis, Cortec Corporation, Polycell International, Salazar Packaging, AP Packaging, Dana Poly, Sancell, ACH Foam Technologies LLC, Alpek SAB de CV, American Excelsior Company, Barnhardt Manufacturing Company, BASF SE, Bayer AG, Buckeye Corrugated, Inc., Caraustar Industries, Inc, Carpenter Co., Cascades, Cellofoam North America Inc and Cold Chain Technology. The various applications of bubble wrap packings are in automotive industry, pharmaceutical industry, e-commerce, electronics industry and others.

Bubble wrap is a malleable transparent plastic material, basically utilized for packaging very fragile products. The bubbles or protruding regularly spaced air-filled hemispheres offer cushioning for various kinds of sensitive delicate products. Bubble wrap packaging is one of the flexible protective packaging that consists of two-layered polyethylene film and air is entrapped inside to form bubbles. Bubble wrap packaging is the most prominent packaging material among all the variants of packaging options available. There increasing demand for consumer goods within the e-commerce sector is the major consumer of bubble wrap packaging with growing profitability.

Consumers’ continuous online shopping has spurred the demand for bubble wraps to reduce damage during transportation of goods from one place to another. However, there is an availability of relatively affordable and eco-friendly alternatives to bubble wrap packaging, such as versatile foam packaging and recycle paper which will also witness a positive growth over the next few years. The booming e-commerce industry in Asia coupled with increasing in consumer’s spending limit particularly in India and China, are complementing the growth in the bubble wrap packaging market. Polyethylene (PE) is the major material used in the manufacturing process of bubble wrap packaging. The temperature-controlled bubble wraps and high-grade bubble wraps will continue to be the fast-selling products in the Asian markets.

Modernization and increase in consumer’s disposable income is driving the growth in the online purchases. Majority of the retailers concentrate to provide damage-free delivery with eco-friendly packaging. With these specific requirements, numerous packaging companies are embracing biodegradable bubble wrap packaging to meet the needs of the increasing consumers. Asian countries have proposed stringent regulations regarding recyclable packaging and are encouraging end-users to prefer degradable materials for packaging. Therefore, there is a rise in investments for the R&D activities by the manufacturers in the bubble wrap packaging market that will increase the development of sustainable packaging materials. Biodegradable bubble wrap packaging is used in food and beverage industry, pharmaceutical and biomedical, home care packing and cosmetics industries.

Biodegradable bubble wrap packaging accounts for a major share within the flexible protective packaging market because it is environmentally friendly and the only by-products after decomposition are small amounts of CO2, H2O and biomass. Small quantities of degradable additives are added into the resin during the production of biodegradable bubble wraps to ensure the quick break down. The increasing population, urbanization, developing economies, industrialization, developing manufacturing sector and increase in international trade are the key factors that will drive the Asian Bubble wrap packaging industry in the next few years.

To know more, click on the link below:

Related Reports:


Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249

Singapore Pharmaceutical Market is driven by Public Private Partnerships in R&D and Expansion of Multinational Companies in Local Market: Ken Research

World Class manufacturing facilities, skilled workforce, expansion of product portfolio by major pharmaceutical companies, government grants and tax incentives were the key factors driving growth in Singapore pharmaceutical Market.

Singapore Pharmaceutical Market can be characterized by the presence of best-in-class infrastructure, integrated and advanced hubs for pharmaceutical manufacturing and research and access to regional markets and skilled workforce. The government has invested in forming competitive clusters to attract research, clinical trials, and manufacturing companies in the pharmaceutical sector. This includes developing infrastructure such as Biopolis, and the Tuas Biomedical Park, tax breaks and business incentives and funding of public-sector research institutes.
Research and Development forms an essential part of the pharmaceutical industry. Various multinational companies have been involved in private-public partnerships in Singapore, particularly with R&D and clinical trials. The Contract Research Organization (CRO) market in Asia grew at a rate of 20% in 2017, with Singapore’s A*STAR leading some of the clinical growth. Few established R&D partnerships in Singapore include Roche’s (Basel, Switzerland) Singapore Hub for Translational Medicine, GlaxoSmithKline’s (Brentford, UK) Academic Centre of Excellence, and Bayer Healthcare’s (Leverkusen, Germany) partnership with the Singapore National Eye Center (SNEC).

Singapore currently hosts more than 50 international biomedical science companies, including GlaxoSmithKline, Takeda, Pfizer, Novartis and Roche. As a result of Singapore’s robust infrastructure, intellectual property (IP) protection, access to regional markets and skilled workforce, many leading biomedical companies have selected Singapore as their global manufacturing base for a wide range of products including Active Pharmaceutical Ingredients, drug products and biologics drug substances.

Singapore pharmaceutical market will continue to incline at a positive growth rate owing to increased investment in biopharmaceutical manufacturing, and growing Contract Research Organization market  

The report titled “Singapore Pharmaceutical Market Outlook to 2022 - by Prescription & OTC Drugs and by Patented & Generic Drugs” by Ken Research suggested a growth at a CAGR of 6.8% in revenue in Singapore Pharmaceutical Market by 2022. Singapore Pharmaceutical market can be characterized by the presence of best-in-class infrastructure, integrated and advanced hubs for pharmaceutical manufacturing and research & access to regional markets and skilled workforce. Many leading biomedical companies such as AbbVie, Pfizer, Ferring Pharmaceuticals and others have selected Singapore as their global manufacturing base

For more information on the research report, refer to below link:

Related Reports by Ken Research

Currently all patented drugs are imported for local consumption. Widely imported patented drugs include high-value specialty drugs for oncology and diabetes management.


Majority pharmaceutical companies are located in West Java and Jakarta due to favorable tax incentives, well developed infrastructure and greater access to medicinal herbs.

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

Seaports Sailing With Logistics Market Outlook: Ken Research

Trade between nations is highly facilitated by sea ports. Huge cargo items that cannot be transported by air arrive at major sea ports around the world daily evident by logistics and shipping market research reports that estimate that nearly 80% of all trade is seaborne hence, it is increasingly important to facilitate good seaport logistics. Studies on port activities are being conducted today to bring out the real importance of seaports although their contribution to an economy is debatable.
These days port activity is no longer limited to just cargo handling. Globalization of complex industrial production processes has increased the importance of sea ports in the global supply chain. It is not only the time and cost of delivery of shipments that matters but also its reliability and predictability.
  1. Many countries are recognizing the bright prospects of the rapidly growing demand by developing their seaports to form regional hubs. Logistics and shipping industry research and market reports reveal that Singapore, Shenzhen, Hong Kong and Dubai are all international hubs of sea trade. These regions are also investing in transshipment facility and efficient transport network.
  2. Better transport infrastructure not only leads to time saving but also leads to growth of trade and sharing of resources. This can significantly benefit both countries and even increase employment. A study conducted on 10 European countries that analyzed the impact of ports on local employment found that every million tons of net port throughput would create around 450-650 jobs in the region. Furthermore, it found that every 10% increase in port throughput can generate a 5%-20% increase in the GDP of the region.
  3. Government intervention can greatly aid port infrastructure and overall gain. India is a good example in this respect. India is the sixteenth largest maritime country in the world with an extensive coastline. The Indian trade and shipping plays a vital role in sustaining the country’s economy and commerce. The Indian Government plays an important role in supporting the seaports sector. It has allowed Foreign Direct Investment (FDI) in development, automation and maintenance of seaport logistics. It has also facilitated a 10 year long tax holiday to further the development and maintenance of ports. Under the National Perspective Plan six new mega ports will be developed in the country.
  4. Certain country’s have an innovative edge over others. Such countries are launching more eco friendly projects and this draws other nations to invest an ever increasing amount in these countries. The global concern for the environment has affected seaport logistics as well. Regions that have adopted the world environmental standards in operational activities are considered superior to others. The international reputation of countries like Singapore is a key driver of its prosperous trade which clearly has resulted in enormous wealth generation.
Sea ports are essential for a country’s overall development and wealth. Regional hubs are seen as an abbreviation for the global sea trade network which has favored countries that have invested in seaport logistics. The resultant trade network will further the country’s development status thereby augmenting employment and technology sharing. India is also making a mark on the global level and demonstrates the strength of government aid and foreign investment. International reputation of a nation also plays a prominent role in its progress especially in respect to the environmental sector. 
Key Factors Considered in the Report:
Logistics and Shipping Market Research Reports
Logistics and Shipping Industry Analysis
Market Research Reports for Logistics
Logistic Market Research Report
Logistics and Transportation Market Research Reports Consulting
Logistics Business Review
Logistics and Shipping Industry Research and Market Reports
To know more, click on the link below:
Contact Us:
Ken Research 
Ankur Gupta, Head Marketing & Communications
+91-9015378249

Singapore Medical Device Market is Driven by Expansion of Medical Facilities and Increased Focus on Home Healthcare Services: Ken Research


The report titled “Singapore Medical Devices Market Outlook to 2022 - by Type of Medical Device (Consumables, Diagnostic Imaging, Patient Aids, Orthopedic & Prosthetics, Dental Products and Others)” by Ken Research suggested a growth at a CAGR of 11.1% in revenue in Singapore medical devices market by 2022. International players have started to focus on new customer centric models such as e-commerce, home health care and DIY health concepts
Ageing population, expansion of major hospitals and clinical laboratories and technology advancements were the key factors driving growth in Singapore medical devices market.
Singapore has the ability to manufacture high quality products and components, including some sophisticated medical devices and equipment. This has made Singapore a preferable alternative for sourcing medical devices. Singapore medical device market has inclined at a positive CAGR driven by expansion of healthcare institutions and increased demand for home care devices such as Elderly Care Monitoring Systems (sensors at home, applications, wearable devices). The number of hospitals increased from 24 in 2012 to 29 in 2016, while the number of clinics increased from 2,403 in 2012 to 2,961 in 2017.
The medical device market underwent various changes in the licensing process which led to reduced paperwork, shortening of approval timeline and more number of licenses being granted in the past 5 years. This supported the medical device manufacturers and distributors in expanding their product portfolio and supports the expansion of healthcare facilities.
Rise in aging population, increasing incidences of chronic diseases have made the home healthcare segment an emerging sector, for medical device manufacturers.  Due to rising emphasis on preventive medicine, the demand for testing, screening and monitoring devices has increased. The potential to reduce healthcare complications and ensure the portability of devices, with high accuracy has created a significant demand for monitoring and testing devices. Increasing activities of telemedicine in consultation, surgery, imaging and cardiology have boosted the demand for advanced technological medical devices.
Technological advancements coupled with growing prevalence of lifestyle diseases will propel the market for medical devices in Singapore. At present, more than 60% of medical devices imported into Singapore are subsequently re-exported as Singapore acts as a major trading hub importing and exporting all kinds of medical devices for re-export to third countries  
To know more, click on the link below:
Related Report  : -
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

Industrialization and Need for Energy Efficient Buildings will Boost Asia Building Thermal Insulation Materials Industry-Ken Research


Thermal insulation materials are used to avoid transfer of heat energy from two differing temperature regions. These materials provide high quality insulation to avoid heat absorption. Thermal insulation materials are segmented on the basis of material type and temperature range of the insulation material. Various building thermal insulation materials are stone wool, fiberglass, plastic foam, and others. Thermal insulation materials are categorized based on temperature ranging from -160° C to -50º C, -49º C to 0ºC, 1ºto 100ºC, and 101ºC to 650ºC. Thermal insulation materials are used in various fields such as buildings, spacecraft, mechanical systems, clothing, natural animal insulation, automotive, and others. The major factors affecting the quality of thermal insulation materials are insulation thickness, specific heat capacity, thermal bridging, surface emissivity, density, and thermal conductivity. Thermal insulation materials are used across various industries to reduce energy consumption by maintaining the required temperature in a particular area. Thermal insulation materials are used in construction industry to maintain temperature range of around 1ºC to 100ºC.

According to the study “Asia Building Thermal Insulation Materials Industry Situation and Prospects Research report”, the key factors driving the growth of thermal insulation materials market are increasing investment in the construction industry, rising number of manufacturing units, and growing urbanization. Asian countries have formulated strict regulations to reduce energy consumption. Developing economies such as India have adopted the Energy Conservation Building Code (ECBC) to help reduce the energy consumption by using green building materials. Other Asian countries are making huge efforts to achieve zero-energy standards in order to reduce the pollution generated in the production of thermal energy. There are increasing environmental concerns which are the key opportunities for the growth of the thermal insulation market in Asia. The greatest market challenge is the high capital cost of thermal insulation materials which is a hurdle in the growth of the thermal insulation market. Residential buildings and commercial offices are the major consumers of more than 30% of the energy which is utilized for the cooling and heating of buildings. Asia accounts for a maximum share of the thermal insulation material market with the introduction of LNG and other similar materials.

Asia building thermal insulation materials market consists of numerous vendors such as BASF, Knauf Insulation, Owens Corning, Paroc Group, ROCKWOOL International, Atlas Roofing, Beijing New Building Material (Group), BYUCKSAN, Cellofoam North America, Dalian Yanmian, The Dow Chemical Company, GAF, Huntsman International, Johns Manville, Kingspan Group, NOVA Chemicals and Saint-Gobain. All the major vendors in the Asia building thermal insulation materials market compete based on factors such as operation cost, innovation, product quality, and price. Various building thermal insulation materials available in Asia are silicate insulation materials, ceramic thermal insulation material, powder polystyrene particles, foamed cement and others. Applications of Asia building thermal insulation materials are in construction of industrial buildings, civil residences and others.

The various other applications in building thermal insulation market are wall insulation, roof insulation, and floor insulation. Building thermal insulation materials reduce the amount of power required to heat or cool a building by minimize the amount of heat that escapes during the winter and limiting hot summer air penetrating into the house. Building thermal insulation is a cost-effective measure in regions with wide range of annual average temperatures. The plastic foam is one such building thermal insulation material that accounts for a major share among all variants of building thermal insulation materials. Plastic foam attributes qualities such as higher thermal resistance (R-Value), versatility, strength, and life span. There is an increasing demand for energy efficient buildings and maximum loss of energy through walls in a building drives the demand for wall thermal insulation materials. The internal and external wall insulation provides thermal, fire, and sound protection for all types of buildings.

Residential and commercial buildings are the largest consumers of energy and carbon-dioxide polluters. Majority of the energy consumption in buildings is used for heating, ventilation, and cooling. There is a huge demand for green buildings with low energy consumption, green roofs and green walls which are likely to increase the demand for building thermal insulation materials in the coming years. The boom in Asia’s housing sector, awareness regarding energy efficient buildings and rising cost of energy encourages the building thermal insulation materials market in Asia in the next few years.

To know more, click on the link below:

Related Reports:


Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249

Learning Apps: Gateway To Ingenious Minds Market Outlook : Ken Research



Being rightly said, “Investment in knowledge pays the best interest.”
Education sector is one of the prominent industry in the world because of the (I) pressures from globalization; (ii) changing supply of and demand for higher education; and (iii) changes in higher education funding. These various challenges determine the development and implementation of various innovative practices to address them. Technology is changing the way we teach and learn at a rapid speed. So, to make learning more interactive and fun with technology the idea of learning apps introduced in the world. One of the great aspect of having tablets, laptops, and desktops in the classroom is the availability of educational learning apps.  Educational Market Research Report Says with these apps students can individually learn, practice, study, and have fun with different subjects, concepts and theories.
NEW ERA: Education Revolution
There are apps to help manage time, convert measurements, lead healthier lifestyles and for fun but a good percentage of apps are by natural education. Students are acquainted to all the apps that contribute towards enhancing their knowledge and skills yet entertain them as well. They are:
Ø  One stop solution -Learning apps saved the hassle to Google everything; they became the platform to undertake any course, any subject, acquire any skill without actually going anywhere. They are accessible anywhere, anytime and on any form of device. Students don’t have to worry about missing any relevant point and could skip irrelevant information which is already known to them.
Ø  Organized and trackable- Application learning is highly systematic, technical and of the smartest way to learn in today’s era. The entire framework, UI and UX of such apps is quite engaging. The organized functioning of these apps makes it simple and easy to track the lost documents from its storage.
Ø  Entertaining and social- The entertainment level of these apps enhance the learning experience for the students generating more active and interactive participation. They ameliorate interest on subjects like math, physics etc which students usually despise.
Ø  Beneficial for all- learning apps have proven their worth to all the potential users, teachers and even parents. Teachers use them to organize their course or make learning fun and interactive for students. Notes stored in the application are easily amendable boosting self learning habits and enticing the budding learners more than mundane classroom.
Educational Industry Analysis states that duolingo is one of the most popular learning app with over 100 million downloads, followed by Photomath with over 50 million downloads and there are others like quizlet, Socratic, edx, meritnation and Byju.
FUTURE PROSPECT/ CONCLUSION
State government of Rajasthan, India launched ‘Dishari’- an educational mobile application that provides free study material for youths preparing for competitive examinations. The app feature interactive quizzes with question related to mathematics, general knowledge, current affairs, computers, reasoning and economics. In the city of Lahore, Pakistan, UNESCO runs a project where they use SMS text to distribute educational context to students in disadvantages area. USA and Europe government is supporting learning apps immensely for growth in education sector.
All these innovative methods of teaching help to identify the true capability and potential of students whilst enjoying videos and subjects taught through games and graphic rather than lengthy texts. They are flexible and are expected to reach the pinnacle in the foreseen future.
For more information, click on the link below:
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204


Tuesday, June 26, 2018

Singapore Pharmaceutical Market is expected to Reach USD 1.8 Billion by 2022: Ken Research

                    Singapore Pharmaceutical Market engages over 50 top global biomedical science firms and 30 public research institutes which aim to create a biomedical ecosystem that concentrates infrastructure and technology

                    Singapore has developed 2 biomedical hubs namely Biopolis and Tuas Biomedical Park which facilitate the cooperation between public sector research centers with private labs and pharmaceutical manufacturing and production.

                    The market is fragmented with multinational companies dominating the space with major focus on research & development activities. Major multinational companies include GSK, Novartis, Roche, Pfizer, Bayer, AstraZeneca, Abbott, Baxter, Maccine and others.

Singapore Pharmaceutical Industry will be led by increased investment in biopharmaceutical manufacturing and growing research & development activities in the space. The best in class research and manufacturing infrastructure will continue to attract foreign investment in the country. For instance, Japan’s Chugai Pharmaceutical, which operates satellite labs throughout Asia, has plans to invest USD 355 million by 2021, to accelerate its research and development (R&D) capabilities in Singapore. Further, Zuellig Pharma who launched its first innovation centre, Zuellig Health Solutions (ZHS), in Singapore in 2017, plans to invest over SGD 50 million over the next five years. Mundipharma plans to start commercial production of antiseptics at its new plant in Singapore in 2019. Apart from innovation in modern medicine, increased demand for pharmaceutical drugs in Asia, which is driven by growing middle class and an ageing population, has increased the market demand for non-essential and therapeutic treatments. The demand for dietary supplements will increase in order to fulfill the nutrition requirement of the people in their busy lifestyle. Due to the prevalence of chronic diseases such as diabetes, heart diseases and others and aging population, revenue from the prescription drugs will continue to occupy the larger share.

The ongoing success of large pharmaceutical companies and increase in biopharmaceutical startups across the country is creating a growing number of new pharma job opportunities in Singapore. Big global drug makers ramp up output and advance automation at their production sites across the country. The opening of new sites such as AbbVie’s biologics manufacturing facility and the ramp up of others including Amgen and Novartis will augment the manufacturing activities of these firms.

The industry will witness a rise in development of technology to support automation and increase productivity. For instance, GSK has been pioneering a technology called continuous manufacturing where instead of making products in batches, materials are constantly added and products removed Emerging Contract Research Organization market, increasing number of mergers & acquisitions coupled with elevating prevalence of chronic and lifestyle diseases will propel Singapore pharmaceutical market revenue in future.

Ken Research in its latest study, “Singapore Pharmaceutical Market Outlook to 2022 - by Prescription & OTC Drugs and by Patented & Generic Drugs”, suggests that demand for pharmaceutical products in the market will continue to grow in Singapore owing to growing public-private partnerships in R&D and clinical trials and expansion of multinational companies in the space.

Key Topics Covered in the Report:
Pharmaceutical Market Size Singapore
OTC Drugs Market Singapore
Prescription Drugs Market Singapore
Patented Drugs Market Singapore
Generics Drug Market Singapore
Singapore Pharmaceutical Industry
Regulations Medicine Market Singapore
New Drug Approvals in Singapore
Value Chain Pharmaceutical Singapore
Competition Singapore Pharmaceutical
Pharmaceutical Manufacturers Singapore
Singapore Pharmaceutical Future
Forecast Revenue Pharmaceutical Singapore
Contract Research Organization Market Singapore
Number of Clinical Trials Singapore
Vitamins and Dietary Supplements Market Singapore
Vitamin Dietary Supplements Market Singapore
CRO Market Regulations Singapore
CRO Market Growth Singapore
Singapore Biopharmaceutical Market
Number of Pharmaceutical Companies Singapore

For more information on the research report, refer to below link:

Products Covered
Prescribed Drugs, OTC Drugs, Biopharmaceuticals, Generic Drugs, Branded Medicine, Vitamin and Dietary Supplements, Drug approvals, Drug Pipeline

Companies Covered:
Haw Par Corporation, Beacon Pharmaceuticals, GSK, Singapore, Roche, Singapore, AstraZeneca, Singapore, Lonza, Singapore, Baxter, Singapore, Abbott, Singapore, MSD, Singapore, Sunward Pharmaceutical, Poli Medical, Union Chemicals and Pharmaceuticals Pte Ltd, Schwabe Pharma Asia Pacific Pte Ltd, and Chemical Company of Malaysia Berhad

Related Reports by Ken Research

Currently all patented drugs are imported for local consumption. Widely imported patented drugs include high-value specialty drugs for oncology and diabetes management.


Majority pharmaceutical companies are located in West Java and Jakarta due to favorable tax incentives, well developed infrastructure and greater access to medicinal herbs.

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204